CLX

Is Clorox Company (CLX) Worth Investing In?

Friday was a great day for Clorox Company investors, who saw their shares rise 5.6% to a price of $156.36 per share. At these higher prices, is the company still fairly valued? If you are thinking about investing, make sure to check the company's fundamentals before making a decision.

Clorox Company Has Elevated P/B and P/E Ratios:

The Clorox Company manufactures and markets consumer and professional products worldwide. The company belongs to the Consumer Discretionary sector, which has an average price to earnings (P/E) ratio of 22.96 and an average price to book (P/B) ratio of 4.24. In contrast, Clorox Company has a trailing 12 month P/E ratio of 248.2 and a P/B ratio of 366.18.

Clorox Company's PEG ratio is 4.54, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Increasing Revenues but Narrowing Margins:

2018 2019 2020 2021 2022 2023
Revenue (MM) $6,124 $6,214 $6,721 $7,341 $7,107 $7,389
Revenue Growth n/a 1.47% 8.16% 9.22% -3.19% 3.97%
Gross Margins 44% 44% 46% 44% 36% 39%
Net Margins 13% 13% 14% 10% 7% 2%
Net Income (MM) $823 $820 $939 $710 $462 $161
Net Interest Expense (MM) $85 $97 $99 $99 $106 $90
Depreciation & Amort. (MM) $166 $180 $180 $211 $224 $236
Earnings Per Share $6.26 $6.32 $7.36 $5.58 $3.73 $1.2
EPS Growth n/a 0.96% 16.46% -24.18% -33.15% -67.83%
Diluted Shares (MM) 130 127 128 124 124 125
Free Cash Flow (MM) $782 $786 $1,292 $945 $535 $930
Capital Expenditures (MM) $194 $206 $254 $331 $251 $228
Current Ratio 1.15 0.86 1.21 0.67 0.86 0.86
Total Debt (MM) $2,284 $2,683 $3,418 $3,084 $2,474 $2,477

Clorox Company has rapidly growing revenues and a flat capital expenditure trend, wider gross margins than its peer group, and generally positive cash flows. However, the firm suffers from declining EPS growth and not enough current assets to cover current liabilities. Finally, we note that Clorox Company has decent net margins with a negative growth trend.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS